Ethereum (ETH/USD Spot) closes above 3,000 USD per token on October 31, 2026
Pending
✦ AI-generated prediction
Published on 1. October 2026
·
Predicted for 31. October 2026
·
Based on: Speculative
ETH is at ~2,700–2,717 USD on Oct 1 (Coinbase / Investing.com). Reaching >3,000 USD by Oct 31 requires +11 % in 30 days. The 2,800 USD level is the critical breakout resistance (usethebitcoin.com). The projection is internally consistent with open platform predictions (ETH >3,200 by Dec 31 2026, ETH >3,500 by Mar 31 2027), implying passage through 3,000 en route. BTC at ~84,000 USD with an open upward prediction for Oct 4 (>86,000) supports broader crypto momentum. Headwinds: PCE inflation data weighed on ETH recently; ETH/BTC ratio shows relative underperformance. No specific Polymarket data for this exact date/level; Cassandra estimates 42 %.
Data basis for this prediction
- ETH/USD Spot ~2.713 USD (Coinbase, 1. Oktober 2026), ~2.688 USD (Investing.com, 1. Oktober 2026)
- ETH hält 2.680 USD; 2.800 USD als Ausbruchszone (usethebitcoin.com Ethereum-Analyse, 1. Oktober 2026)
- BTC/USD ~83.900 USD (Coinbase, 1. Oktober 2026); offene Plattform-Vorhersage BTC >86.000 USD am 4. Oktober 2026
- Offene Plattform-Pfad: ETH >3.200 USD (31.12.2026) und ETH >3.500 USD (31.3.2027) — Cassandra.news
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
💻 Technology
✦ AI
Ethereum trades at $2,680 on Oct 1, 2026 (CoinGecko). The $3,500 threshold is 30.6% above current price — achievable within 6 months but ambitious. Forecaster consensus for October 2026 alone: DailyForex $2,600–$3,100; CoinDCX $2,950; Changelly $3,045–$3,070 (minimum target). The $3,500 level thus represents a natural projection of October momentum into Q1 2027. Bullish drivers: ETH staking yields remain attractive; Layer-2 adoption (Base, Arbitrum, Optimism) accelerates network utilization; historical BTC halving cycle patterns favor altcoin rallies from Q4 2026. Headwinds: US SEC regulatory action, macro-driven risk aversion, or decoupling from BTC. No direct Polymarket market found for this horizon; 30% probability conservatively derived from forecaster spread and ETH volatility profile.
💻 Technology
✦ AI
The Royal Swedish Academy of Sciences announces the Nobel Prize in Chemistry on October 7. Shankar Balasubramanian and David Klenerman (both University of Cambridge) are the main favorites on small, illiquid prediction markets (Kalshi, Polymarket) for their invention of Sequencing by Synthesis (SBS), the foundation of modern NGS platforms — above all Illumina — which has revolutionized personalized medicine, oncology, and infectious disease epidemiology. Other strongly backed candidates: Pieter Cullis (UBC) for lipid nanoparticle technology (mRNA vaccines) and the skeletal editing trio Sarpong/Levin/Miranda. Kalshi: Balasubramanian/Klenerman as frontrunners without published exact odds; market positioning per Chemistry World and The Scientist implies approximately 20–28% for this duo. Nobel committees historically act surprisingly; probability set at 25%.
💻 Technology
✦ AI
ASML (NASDAQ/Euronext: ASML) guided Q3 2026 net sales to €11.0–12.0 billion at 55–57% gross margin. In Q2 2026 the company posted €9.3 billion net sales, beating guidance ('Q2 2026 beats guidance as AI demand lifts outlook'). Full-year 2026 guidance was raised to €43–45 billion net sales. Exceeding the guidance midpoint of €11.5 billion requires +23.7% sequential growth from Q2 — consistent with ASML's typical H2 seasonal strength driven by EUV system deliveries. Given the Q2 guidance beat and raised full-year outlook, a midpoint beat is plausible at ~62%. No specific Polymarket price found.